You searched for "investigation"
Prostate cancer: Black men more likely to be diagnosed at later stages
Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...
Phase two trial of SAbR for primary RCC
A study focused on stereotactic ablative radiotherapy (SAbR) as a treatment for primary renal cell carcinoma (RCC) has yielded significant findings. The primary objective of the study was successfully met, demonstrating a 94% local control rate at one year among...Urethral diverticulum: a review of the literature and local experience
Urethral diverticula are an uncommon finding on imaging. They are focal outpouchings of the urethra into the periurethral / urethrovaginal space, occurring more frequently in females (up to 6% of women) [1]. These diverticula are becoming more prevalent in clinical...All Aboard the Toilet Train: Children’s charity launches intervention to support the influx of reception class children who are not toilet trained
With one in four children in England and Wales starting school not toilet trained, teachers are facing a tricky time in September as some new reception class children may arrive untrained. In response, ERIC, The Children’s Bowel & Bladder Charity...MOOCs
Technology has always been intimately linked to new educational methods. This has included distance learning, learning through multimedia and finally computer-based learning. Massive Open Online Courses (MOOCs) are so called because they can be taken by an unlimited number of...
Solifenacin for children and adolescents with overactive bladders
Solifenacin (VESIcare®) is the second-line anti-muscarinic medication of choice for my patients with overactive bladder (oxybutynin being my initial choice). However, currently, it remains unlicensed for use in children. Newgreen et al. have evaluated the long-term safety and efficacy of...
Solifenacin and mirabegron are safe and effective in combination
Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...In conversation with Paula Allchorne
We were delighted to catch up with Paula Allchorne, Chair of the European Association of Urology Nurses (EAUN) about her career in urological nursing and her plans for the association. Can you tell us a little bit about what led...Urology around the world: Pioneering paths – my journey as the first and only Italian female urologist in the Muslim world
Maria Colavita. As the first and only Italian female urologist practising in the Muslim world, my journey has been shaped by ambition, grief, cultural curiosity, and ultimately, profound transformation. What began with an unexpected invitation has become a story of...
